These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28470586)

  • 41. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
    Elgindy NA; Mehanna MM; Mohyeldin SM
    Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H
    Liang X; Chen YL; Jiang XJ; Wang SM; Zhang JW; Gui SY
    Eur J Pharm Sci; 2017 Mar; 100():155-162. PubMed ID: 28063969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress in the use of microemulsions for transdermal and dermal drug delivery.
    Ita K
    Pharm Dev Technol; 2017 Jun; 22(4):467-475. PubMed ID: 26931453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanovesicular carrier-mediated transdermal delivery of tadalafil: i-formulation and physicsochemical characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    Drug Dev Ind Pharm; 2015 May; 41(5):714-21. PubMed ID: 24669976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermal peptide delivery using colloidal carrier systems.
    Goebel A; Neubert RH
    Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Progress in Transdermal Nanocarriers and Their Surface Modifications.
    Yu Z; Meng X; Zhang S; Chen Y; Zhang Z; Zhang Y
    Molecules; 2021 May; 26(11):. PubMed ID: 34064297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential application of novel liquid crystal nanoparticles of isostearyl glyceryl ether for transdermal delivery of 4-biphenyl acetic acid.
    Fujii MY; Asakawa Y; Fukami T
    Int J Pharm; 2020 Feb; 575():118935. PubMed ID: 31816353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanogels for Skin Cancer Therapy via Transdermal Delivery: Current Designs.
    Tran PHL; Duan W; Lee BJ; Tran TTD
    Curr Drug Metab; 2019; 20(7):575-582. PubMed ID: 31237201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
    Ham AS; Buckheit RW
    Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
    Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
    Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic delivery of antihypertensive drugs via skin.
    Güngör S; Ozsoy Y
    Ther Deliv; 2012 Sep; 3(9):1101-16. PubMed ID: 23035594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in peptides for enhancing transdermal macromolecular drug delivery.
    Ruan R; Chen M; Zou L; Wei P; Liu J; Ding W; Wen L
    Ther Deliv; 2016; 7(2):89-100. PubMed ID: 26769200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microfluidic-aided fabrication of nanoparticles blend based on chitosan for a transdermal multidrug delivery application.
    Shamsi M; Zahedi P; Ghourchian H; Minaeian S
    Int J Biol Macromol; 2017 Jun; 99():433-442. PubMed ID: 28274863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.